CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Operating expenses:
Research and development	$ 94,315	$ 64,550
General and administrative	31,721	28,868
Total operating expenses	126,036	93,418
Loss from operations	(126,036)	(93,418)
Other income:
Interest income	8,173	1,324
Total other income	8,173	1,324
Net loss	$ (117,863)	$ (92,094)
Net loss per share attributable to common stockholders, basic	$ (1.75)	$ (2.33)
Net loss per share attributable to common stockholders, diluted	$ (1.75)	$ (2.33)
Weighted-average common shares outstanding, basic	67,191,973	39,551,420
Weighted-average common shares outstanding, diluted	67,191,973	39,551,420
Other comprehensive income (loss):
Unrealized gain (loss) on available for sale investments	$ 693	$ (770)
Total other comprehensive income (loss)	693	(770)
Comprehensive loss	$ (117,170)	$ (92,864)